Vaccine Attitudes and Practices of Hospital Specialists (SPECIVAC)

April 16, 2021 updated by: Assistance Publique - Hôpitaux de Paris
This study aims to evaluate the perceptions and knowledge of hospital specialists regarding vaccine recommendations targeting their patients, to study their behavior with respect to these recommendations and to quantify their vaccine hesitancy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1851

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Annecy, France, 74370
        • CRC Annecy
      • Besançon, France, 25030
        • CIC Besançon
      • Clermont-Ferrand, France, 63003
        • CIC Clermont-Ferrand
      • Dijon, France, 21079
        • CIC Dijon
      • Lille, France, 59045
        • CIC Lille
      • Limoges, France, 87042
        • CIC Limoges
      • Lyon, France, 69437
        • Service d'Hygiène, Epidémiologie et Prévention, Groupement Hospitalier Edouard Herriot et Unité de recherche clinique ne Immunologie du centre hospitalier Lyon Sud
      • Montpellier, France, 34295
        • CIC Montpellier
      • Nancy, France, 54511
        • Service de maladies infectieuses Nancy
      • Nîmes, France, 30029
        • Service de maladies infectieuses Nîmes
      • Rennes, France, 35033
        • CIC Rennes
      • Strasbourg, France, 67000
        • CIC Strasbourg
    • Ile De France
      • Paris, Ile De France, France, 75014
        • CIC Cochin Pasteur
      • Paris, Ile De France, France, 75877
        • CIC Bichat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  • Physicians with a frequent activity of practice and advice vaccines, called "vaccinators" (most medical specialties): 100% of those meeting the inclusion criteria will be contacted for inclusion
  • Physicians "no or weak vaccinators" (anesthesiologists, surgeons, psychiatrists…): 30% of those meeting the inclusion criteria will be chosen by drawing lots

Description

Inclusion Criteria:

  • To be a physician in one of the participating institutions
  • Or to be a contract physician in participating institutions

Exclusion Criteria:

  • Interns
  • Attached practitioners
  • Emergency physicians

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Proportions of Hospital Specialists (HS) with knowledge of vaccine recommendations targeting their patients
Time Frame: 15 minutes
15 minutes
Proportions of HS regularly recommending recommended vaccines to their patients
Time Frame: 15 minutes
15 minutes
Proportions of HS with doubts about recommended vaccines
Time Frame: 15 minutes
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Link between perception of benefits and risks of vaccines, knowledge of vaccine-preventable diseases, trust in different sources of information and vaccine hesitancy will be measured by questionnaire (measure by multiple logistic regressions)
Time Frame: 15 minutes
15 minutes
Measure of attitudes and practices of HS vis-a-vis to vaccination and their specialty by questionnaire
Time Frame: 15 minutes
number of HS vaccinator or not by specialty in connection with their attitudes and practices
15 minutes
Percentages of HS feeling sufficiently trained or confident to explain to patients about vaccines
Time Frame: 15 minutes
15 minutes
Percentages of HS claiming to be vaccinated, by type of vaccine
Time Frame: 15 minutes
15 minutes
Percentages of HS children reported vaccinated by type of vaccine
Time Frame: 15 minutes
15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Odile LAUNAY, Professor, CIC 1417 Centre d'investigation clinique
  • Study Chair: Pierre VERGER, MD, ORS PACA UMR 912 SESSTIM

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2018

Primary Completion (Actual)

October 4, 2019

Study Completion (Actual)

October 4, 2019

Study Registration Dates

First Submitted

December 11, 2017

First Submitted That Met QC Criteria

January 10, 2018

First Posted (Actual)

January 18, 2018

Study Record Updates

Last Update Posted (Actual)

April 19, 2021

Last Update Submitted That Met QC Criteria

April 16, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • NI16019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaccine Practice

Clinical Trials on Questionnaire

3
Subscribe